RxNorm Semantic Concepts Index - 596
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "596".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 596 | Alprazolam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 596 | Alprazolam | Designated preferred name (PT) | YES | |
| RxCUI: 596 | Alprazolam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596 | Alprazolam | Full form of descriptor (FN) | YES | |
| RxCUI: 596 | Alprazolam | Designated preferred name (PT) | YES | |
| RxCUI: 596 | Alprazolam | Full form of descriptor (FN) | YES | |
| RxCUI: 5960 | Ion exchange resin | Designated preferred name (PT) | NO | |
| RxCUI: 5960 | Ion exchange resin | Full form of descriptor (FN) | NO | |
| RxCUI: 5960 | Ion exchange resin | Designated preferred name (PT) | NO | |
| RxCUI: 5960 | Ion exchange resin | Full form of descriptor (FN) | NO | |
| RxCUI: 596050 | choline / magnesium salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 596119 | Tarantula venom | Designated preferred name (PT) | NO | |
| RxCUI: 596119 | Tarantula venom | Full form of descriptor (FN) | NO | |
| RxCUI: 59617 | Hb 88(F4), Leu-pro | British preferred term (PTGB) | NO | |
| RxCUI: 59617 | Hb 88(F4), Leu-pro | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59617 | Hb 88(F4), Leu-pro | Designated preferred name (PT) | NO | |
| RxCUI: 59617 | Hb 88(F4), Leu-pro | Full form of descriptor (FN) | NO | |
| RxCUI: 596205 | ramelteon | Full form of descriptor (FN) | YES | |
| RxCUI: 596205 | ramelteon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 596205 | ramelteon | Designated preferred name (PT) | YES | |
| RxCUI: 596205 | ramelteon | Full form of descriptor (FN) | YES | |
| RxCUI: 596205 | ramelteon | Designated preferred name (PT) | YES | |
| RxCUI: 59623 | 3-dehydrosphinganine reductase | Designated preferred name (PT) | NO | |
| RxCUI: 59623 | 3-dehydrosphinganine reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 59629 | Proteoglycanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59629 | Proteoglycanase | Designated preferred name (PT) | NO | |
| RxCUI: 59629 | Proteoglycanase | Full form of descriptor (FN) | NO | |
| RxCUI: 59629 | Proteoglycanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59635 | Aspartate acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 59635 | Aspartate acetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 59636 | buclizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59636 | buclizine | Designated preferred name (PT) | NO | |
| RxCUI: 59636 | buclizine | Full form of descriptor (FN) | NO | |
| RxCUI: 59636 | buclizine | Designated preferred name (PT) | NO | |
| RxCUI: 59636 | buclizine | Full form of descriptor (FN) | NO | |
| RxCUI: 59639 | Atosiban | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59639 | Atosiban | Designated preferred name (PT) | NO | |
| RxCUI: 59639 | Atosiban | Full form of descriptor (FN) | NO | |
| RxCUI: 59639 | Atosiban | Designated preferred name (PT) | NO | |
| RxCUI: 59639 | Atosiban | Full form of descriptor (FN) | NO | |
| RxCUI: 59652 | Hb 71(E15), Phe-ser | British preferred term (PTGB) | NO | |
| RxCUI: 59652 | Hb 71(E15), Phe-ser | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59652 | Hb 71(E15), Phe-ser | Designated preferred name (PT) | NO | |
| RxCUI: 59652 | Hb 71(E15), Phe-ser | Full form of descriptor (FN) | NO | |
| RxCUI: 59653 | Hb 80(EF4), Asn-lys | British preferred term (PTGB) | NO | |
| RxCUI: 59653 | Hb 80(EF4), Asn-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59653 | Hb 80(EF4), Asn-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59653 | Hb 80(EF4), Asn-lys | Designated preferred name (PT) | NO | |
| RxCUI: 59653 | Hb 80(EF4), Asn-lys | Full form of descriptor (FN) | NO | |
| RxCUI: 596548 | metavanadate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 596554 | Vildagliptin | Full form of descriptor (FN) | NO | |
| RxCUI: 596554 | Vildagliptin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 596554 | Vildagliptin | Designated preferred name (PT) | NO | |
| RxCUI: 596554 | Vildagliptin | Full form of descriptor (FN) | NO | |
| RxCUI: 596554 | Vildagliptin | Designated preferred name (PT) | NO | |
| RxCUI: 596565 | Nucleoside analogue-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 596565 | Nucleoside analogue-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 596565 | Nucleoside analogue-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 596565 | Nucleoside analogue-containing product | British preferred term (PTGB) | NO | |
| RxCUI: 596565 | Nucleoside analogue-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 596565 | Nucleoside analogue-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 5966 | Iopamidol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 5966 | Iopamidol | Designated preferred name (PT) | YES | |
| RxCUI: 5966 | Iopamidol | Full form of descriptor (FN) | YES | |
| RxCUI: 5966 | Iopamidol | Designated preferred name (PT) | YES | |
| RxCUI: 5966 | Iopamidol | Full form of descriptor (FN) | YES | |
| RxCUI: 59664 | 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase | Designated preferred name (PT) | NO | |
| RxCUI: 59664 | 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 5967 | Iopanoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 5967 | Iopanoic acid | Designated preferred name (PT) | NO | |
| RxCUI: 5967 | Iopanoic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 5967 | Iopanoic acid | Designated preferred name (PT) | NO | |
| RxCUI: 5967 | Iopanoic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 596702 | Menactra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 596712 | iodophors | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 596717 | Clodronate | Designated preferred name (PT) | NO | |
| RxCUI: 596717 | Clodronate | Full form of descriptor (FN) | NO | |
| RxCUI: 596718 | butyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 596723 | Cerivastatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 596723 | Cerivastatin | Designated preferred name (PT) | NO | |
| RxCUI: 596723 | Cerivastatin | Full form of descriptor (FN) | NO | |
| RxCUI: 596723 | Cerivastatin | Designated preferred name (PT) | NO | |
| RxCUI: 596723 | Cerivastatin | Full form of descriptor (FN) | NO | |
| RxCUI: 596724 | Anagrelide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 596724 | Anagrelide | Designated preferred name (PT) | YES | |
| RxCUI: 596724 | Anagrelide | Full form of descriptor (FN) | YES | |
| RxCUI: 596724 | Anagrelide | Designated preferred name (PT) | YES | |
| RxCUI: 596724 | Anagrelide | Full form of descriptor (FN) | YES | |
| RxCUI: 59677 | Hb 95(G2), Pro-leu | British preferred term (PTGB) | NO | |
| RxCUI: 59677 | Hb 95(G2), Pro-leu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59677 | Hb 95(G2), Pro-leu | Designated preferred name (PT) | NO | |
| RxCUI: 59677 | Hb 95(G2), Pro-leu | Full form of descriptor (FN) | NO | |
| RxCUI: 5968 | iofendylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 5968 | iofendylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 596818 | codeine 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine 2.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 596818 | codeine 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine 2.5 MG/ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 596843 | lansoprazole 15 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596843 | lansoprazole 15 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 596843 | lansoprazole 15 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 596843 | lansoprazole 15 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 596843 | lansoprazole 15 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 596843 | lansoprazole 15 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 596881 | carmustine 3.3 MG/ML Injectable Solution [BiCNU] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 596881 | carmustine 3.3 MG/ML Injectable Solution [BiCNU] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 596881 | carmustine 3.3 MG/ML Injectable Solution [BiCNU] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 596918 | Prevacid 15 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 596918 | Prevacid 15 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596918 | Prevacid 15 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596921 | lansoprazole Extended Release Suspension [Prevacid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 596922 | lansoprazole 0.5 MG/ML Extended Release Suspension [Prevacid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 596922 | lansoprazole 0.5 MG/ML Extended Release Suspension [Prevacid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 596923 | lansoprazole 1 MG/ML Extended Release Suspension [Prevacid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 596923 | lansoprazole 1 MG/ML Extended Release Suspension [Prevacid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 596925 | duloxetine 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 596925 | duloxetine 20 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596926 | DULoxetine 20 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 596927 | duloxetine 20 MG [Cymbalta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 596927 | duloxetine 20 MG [Cymbalta] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596928 | Cymbalta 20 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596928 | Cymbalta 20 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596928 | Cymbalta 20 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596928 | Cymbalta 20 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596928 | Cymbalta 20 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 596928 | Cymbalta 20 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596929 | duloxetine 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 596929 | duloxetine 30 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596930 | DULoxetine 30 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 596931 | duloxetine 30 MG [Cymbalta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 596931 | duloxetine 30 MG [Cymbalta] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596932 | Cymbalta 30 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596932 | Cymbalta 30 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596932 | Cymbalta 30 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596932 | Cymbalta 30 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596932 | Cymbalta 30 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 596932 | Cymbalta 30 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596933 | duloxetine 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 596933 | duloxetine 60 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 596934 | DULoxetine 60 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 596935 | glycerin 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 596936 | glycerin 5.4 GM per 5.4 mL Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 596936 | glycerin 5.4 GM per 5.4 mL Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596936 | glycerin 5.4 GM per 5.4 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596939 | potassium iodide 24 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 596940 | iodine 2 % / potassium iodide 2.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 596940 | iodine 2 % / potassium iodide 2.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596940 | iodine 2 % / potassium iodide 2.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596940 | iodine 2 % / potassium iodide 2.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 596940 | iodine 2 % / potassium iodide 2.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 596942 | allantoin / dimethicone Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 59695 | Chloropyrilene | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59695 | Chloropyrilene | Full form of descriptor (FN) | NO | |
| RxCUI: 59695 | Chloropyrilene | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59695 | Chloropyrilene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59695 | Chloropyrilene | Designated preferred name (PT) | NO | |
| RxCUI: 59695 | Chloropyrilene | Designated preferred name (PT) | NO | |
| RxCUI: 59695 | Chloropyrilene | Full form of descriptor (FN) | NO | |
| RxCUI: 596955 | tetracycline Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 596956 | tetracycline hydrochloride 12.7 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 596958 | tetracycline Drug Implant [Actisite] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 596959 | tetracycline hydrochloride 12.7 MG Drug Implant [Actisite] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 596959 | tetracycline hydrochloride 12.7 MG Drug Implant [Actisite] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |